Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth J Perlman

Showing results (101-110 of 124) with videos related to

Pageof 13
Sort By:
Expert Review of Anticancer Therapy|August 3, 2011
Management of adults with Wilms' tumor: recommendations based on international consensusHeidi Segers, Marry M van den Heuvel-Eibrink, Kathy Pritchard-Jones, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 27, 2019
Augmentation of Therapy for Combined Loss of Heterozygosity 1p and 16q in Favorable Histology Wilms Tumor: A Children's Oncology Group AREN0532 and AREN0533 Study ReportDavid B Dix, Conrad V Fernandez, Yueh-Yun Chi, et al.
Annals of Surgical Oncology|January 24, 2022
Kidney Preservation and Wilms Tumor Development in Children with Diffuse Hyperplastic Perilobar Nephroblastomatosis: A Report from the Children's Oncology Group Study AREN0534Peter F Ehrlich, Brett Tornwall, Murali M Chintagumpala, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 6, 2020
Activity of Vincristine and Irinotecan in Diffuse Anaplastic Wilms Tumor and Therapy Outcomes of Stage II to IV Disease: Results of the Children's Oncology Group AREN0321 StudyNajat C Daw, Yueh-Yun Chi, John A Kalapurakal, et al.
Molecular Oncology|February 25, 2014
Validation of a prognostic multi-gene signature in high-risk neuroblastoma using the high throughput digital NanoString nCounter™ systemThomas P Stricker, Andres Morales La Madrid, Alexandre Chlenski, et al.
Cancer Research|August 16, 2023
Integrative Genomic Analyses Identify LncRNA Regulatory Networks across Pediatric Leukemias and Solid TumorsApexa Modi, Gonzalo Lopez, Karina L Conkrite, et al.
Annals of Surgery|November 5, 2016
Clinical Outcome and Biological Predictors of Relapse After Nephrectomy Only for Very Low-risk Wilms Tumor: A Report From Children's Oncology Group AREN0532Conrad V Fernandez, Elizabeth J Perlman, Elizabeth A Mullen, et al.
Annals of Surgery|February 10, 2010
Long-term outcomes for infants with very low risk Wilms tumor treated with surgery alone in National Wilms Tumor Study-5Robert C Shamberger, James R Anderson, Norman E Breslow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 7, 2017
Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group Study AREN0532Conrad V Fernandez, Elizabeth A Mullen, Yueh-Yun Chi, et al.
Annals of Surgery|August 11, 2017
Results of the First Prospective Multi-institutional Treatment Study in Children With Bilateral Wilms Tumor (AREN0534): A Report From the Children's Oncology GroupPeter Ehrlich, Yuen Y Chi, Murali M Chintagumpala, et al.
Pageof 13

Showing results (101-110 of 124) with videos related to

Sort By:
Pageof 13
Expert Review of Anticancer Therapy|August 3, 2011
Management of adults with Wilms' tumor: recommendations based on international consensusHeidi Segers, Marry M van den Heuvel-Eibrink, Kathy Pritchard-Jones, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 27, 2019
Augmentation of Therapy for Combined Loss of Heterozygosity 1p and 16q in Favorable Histology Wilms Tumor: A Children's Oncology Group AREN0532 and AREN0533 Study ReportDavid B Dix, Conrad V Fernandez, Yueh-Yun Chi, et al.
Annals of Surgical Oncology|January 24, 2022
Kidney Preservation and Wilms Tumor Development in Children with Diffuse Hyperplastic Perilobar Nephroblastomatosis: A Report from the Children's Oncology Group Study AREN0534Peter F Ehrlich, Brett Tornwall, Murali M Chintagumpala, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 6, 2020
Activity of Vincristine and Irinotecan in Diffuse Anaplastic Wilms Tumor and Therapy Outcomes of Stage II to IV Disease: Results of the Children's Oncology Group AREN0321 StudyNajat C Daw, Yueh-Yun Chi, John A Kalapurakal, et al.
Molecular Oncology|February 25, 2014
Validation of a prognostic multi-gene signature in high-risk neuroblastoma using the high throughput digital NanoString nCounter™ systemThomas P Stricker, Andres Morales La Madrid, Alexandre Chlenski, et al.
Cancer Research|August 16, 2023
Integrative Genomic Analyses Identify LncRNA Regulatory Networks across Pediatric Leukemias and Solid TumorsApexa Modi, Gonzalo Lopez, Karina L Conkrite, et al.
Annals of Surgery|November 5, 2016
Clinical Outcome and Biological Predictors of Relapse After Nephrectomy Only for Very Low-risk Wilms Tumor: A Report From Children's Oncology Group AREN0532Conrad V Fernandez, Elizabeth J Perlman, Elizabeth A Mullen, et al.
Annals of Surgery|February 10, 2010
Long-term outcomes for infants with very low risk Wilms tumor treated with surgery alone in National Wilms Tumor Study-5Robert C Shamberger, James R Anderson, Norman E Breslow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 7, 2017
Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group Study AREN0532Conrad V Fernandez, Elizabeth A Mullen, Yueh-Yun Chi, et al.
Annals of Surgery|August 11, 2017
Results of the First Prospective Multi-institutional Treatment Study in Children With Bilateral Wilms Tumor (AREN0534): A Report From the Children's Oncology GroupPeter Ehrlich, Yuen Y Chi, Murali M Chintagumpala, et al.
Pageof 13